UCLA researchers use lipid nanoparticles to insert full CFTR gene into airway cells, restoring function and opening new ...
Engineers at the University of Pennsylvania and Rice University have refined a technology for editing individual genetic ...
WASHINGTON, Feb 23 (Reuters) - The U.S. Food and Drug Administration proposed on Monday a new framework to speed approvals of ...
The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would ...
As cell and gene therapies move into more hospitals and cancer centers, health system leaders are learning that clinical ...
After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...
The FDA expects a flood of applications for a new "plausible mechanism pathway" for approval of bespoke gene-editing treatments.
7d
Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...
Forget Vertex Pharmaceuticals -- CRISPR Therapeutics is a better buy right now.
DNA is the blueprint of life. Genes encode proteins and serve as the body's basic components. However, building a functioning ...
Inside every cell, thousands of molecular signals collide, overlap, and compensate, obscuring the true drivers of gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results